You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 12, June 26, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Abstract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Sleep Apnea
 •Quality of Life
 •Women's Health
 •Menopause
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Severe Hot Flashes Are Associated With Chronic Insomnia

Maurice M. Ohayon, MD, DSc, PhD

Arch Intern Med. 2006;166:1262-1268.

ABSTRACT

Background  Because hot flashes can occur during the night, their presence has been frequently associated with insomnia in women with symptoms of menopause. However, many factors other than hot flashes or menopause can be responsible for insomnia, and several factors associated with insomnia in the general population are also commonly observed in perimenopausal and postmenopausal women who have hot flashes.

Methods  A random sample of 3243 subjects (aged ≥18 years) representative of the California population was interviewed by telephone. Included were 982 women aged 35 to 65 years. Women were divided into 3 groups according to menopausal status: premenopause (57.2%), perimenopause (22.3%), and postmenopause (20.5%). Hot flashes were counted if they were present for at least 3 days per week during the last month and were classified as mild, moderate, or severe according to their effect on daily functioning. Chronic insomnia was defined as global sleep dissatisfaction, difficulty initiating sleep, difficulty maintaining sleep, or nonrestorative sleep, for at least 6 months. Diagnoses of insomnia were assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, classification.

Results  Prevalence of hot flashes was 12.5% in premenopause, 79.0% in perimenopause, and 39.3% in postmenopause. Prevalence of chronic insomnia was reported as 36.5% in premenopause, 56.6% in perimenopause, and 50.7% in postmenopause (P<.001). Prevalence of symptoms of chronic insomnia increased with the severity of hot flashes, reaching more than 80% in perimenopausal women and postmenopausal women who had severe hot flashes. In multivariate analyses, severe hot flashes were significantly associated with symptoms and a diagnosis of chronic insomnia. Poor health, chronic pain, and sleep apnea were other significant factors associated with chronic insomnia.

Conclusions  Severe hot flashes are strongly associated with chronic insomnia in midlife women. The presence of hot flashes should be systematically investigated in women with insomnia. Treating hot flashes could improve sleep quality and minimize the deleterious consequences of chronic insomnia.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

It has been reported that insomnia increases substantially with age in men and women, but it is more life altering in women. The prevalence of insomnia in women coincides with the age when menopause begins.1

Hot flashes are climacteric vasomotor symptoms that affect as many as 85% of menopausal women2-9 and frequently persist for as long as 5 years after the last menstrual cycle. They are also one of the first climacteric symptoms to appear in premenopausal women; nearly 20% of premenopausal women in their late 40s report hot flashes,7, 10-11 with severity increasing in late perimenopause and postmenopause.11

Because hot flashes can occur during the night, their presence has been frequently associated with sleep disturbances, mainly insomnia, in women with symptoms of menopause.2, 7, 12-14 However, many factors other than hot flashes or menopause can be responsible for insomnia, and several factors associated with insomnia in the general population are also commonly observed in perimenopausal and postmenopausal women who have hot flashes. This is the case, for example, with anxiety and depression, which occur frequently in both insomnia and menopause.15-17 Poor health status and sleep apnea, 2 additional factors associated with insomnia, increase with age, putting perimenopausal and postmenopausal women at greater risk of insomnia.18-19 Consequently, the lack of adequate controls for other factors associated with insomnia may influence insomnia’s association with hot flashes.

The purpose of this study, performed in a general population, was to assess the prevalence and severity of hot flashes in premenopausal, perimenopausal, and postmenopausal women aged 35 to 65 years and to determine whether hot flashes remain associated with insomnia after controlling for variables commonly associated with insomnia.


METHODS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

SAMPLE

The study was performed from June 2003 to April 2004. The target population was the 24 million adults (aged ≥18 years) living in California. Of 3787 eligible individuals, 3243 subjects (85.6%) participated in the survey.

PROCEDURES

In the first stage, telephone numbers were pulled proportional to the population of each county in California. In the second stage, during the telephone contact, the Kish20 method was used to select 1 respondent per household. This method allowed for selection of a respondent on the basis of age and sex to maintain a sample representative of these 2 variables.

Interviewers explained the goals of the study to potential participants and requested verbal consent before conducting the interview. The study was reviewed by the Stanford University Institutional Review Board, Stanford, Calif.

Subjects who declined to participate or who stopped answering questions before completing half of the interview were classified as refusing to participate. Excluded from the study were subjects who were not fluent in English, who had a hearing or speech impairment, or who had an illness that precluded their being interviewed. Telephone numbers were discarded and replaced only after a minimum of 10 unsuccessful telephone attempts. In the final sample, 21.4% of telephone numbers were unlisted.

The mean (±SD) duration of the interviews was 74.5 (±37.8) minutes. An interview could be completed with more than 1 telephone call if it exceeded 60 minutes or at the request of the participant.

INSTRUMENT

Interviewers used the Sleep-EVAL,21-22 knowledge-based, expert system. This computer software is specially designed to administer questionnaires and conduct epidemiologic studies in the general population. The interview begins with a questionnaire administered to all participants. It includes, in order, sociodemographic information, sleep-wake schedule, sleeping habits, sleep disturbance symptoms, medical and paramedical consultations and hospitalizations during the last 12 months, physical disease information, use of prescribed and nonprescribed drugs, health quality assessment scale, alimentation information, fatigue scale, pain questionnaire, and information about height, weight, and, for women, questions about menopause. After this information is collected, the system begins the diagnostic exploration of sleep and mental disorders. On the basis of responses provided by a subject, the system formulates an initial diagnostic hypotheses that it attempts to confirm or reject by asking supplemental questions or by deduction. Concurrent diagnoses are allowed in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,23 and The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual.24 The system terminates the interview when all diagnostic possibilities have been exhausted. The system has been tested in various contexts, including clinical psychiatry and sleep disorders clinics.25-28 In psychiatry, {kappa} values have ranged from 0.44 (schizophrenia disorders) to 0.78 (major depressive disorders)25-26 and, in sleep medicine, {kappa} values have ranged from 0.68 to 0.92.27-28

DEFINITIONS

Menopausal status was classified in accord with the World Health Or ganization29 definition, as follows:

  • Premenopause: Women aged 35 years or older who reported having regular menstrual cycles in the last year.
  • Perimenopause: Women who reported irregular menstrual cycles during the last year and had at least 1 menstrual bleeding in the previous year.
  • Postmenopause: Women who reported no menstrual bleeding during the last 12 months.

Hot flashes had to occur at least 3 days per week during the last month. Severity of hot flashes was defined as follows:

  • Mild: Most of the time, hot flashes are limited to a sensation of heat without sweating.
  • Moderate: Most of the time, hot flashes are a sensation of heat with sweating, but not enough to prevent the pursuit of an activity.
  • Severe: Most of the time, hot flashes are a sensation of heat with sweating causing the woman to stop her activity.

Symptoms of insomnia were defined as difficulty initiating sleep (DIS), difficulty maintaining sleep (DMS), or nonrestorative sleep (NRS). Global sleep dissatisfaction (GSD)30 was defined as a complaint about sleep quality or quantity. It was required for all these symptoms to be present at the time of the interview at least 3 nights per week for at least the past 6 months. Chronic insomnia was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, classification, with the exception that insomnia duration was set at 6 months rather than 1 month.

OTHER VARIABLES ASSESSED

The following data were also collected:

  • Sociodemographic variables: age, sex, marital status, race/ethnicity, occupation, and income.
  • Health status variables: subjective assessment of health quality (from very poor to excellent), physical diseases at the time of the interview, chronic pain (lasting at least 6 months), blood pressure, medications (prescribed or not prescribed, including hormone therapy), and medical consultations during the previous year.
  • Height and weight, to calculate body mass index (calculated as weight in kilograms divided by the square of height in meters). The body mass index categories were defined as recommended by the National Heart, Lung, and Blood Institute.31
  • Breathing pauses during sleep lasting some seconds were coded as present when the subject reported a frequency of at least 3 nights per week.

STATISTICAL ANALYSES

Bivariate analyses were performed using the {chi}2 test or the Fisher exact test when n values were smaller than 5. Logistic regressions were used to compute the odds ratios (ORs) associated with reports of insomnia. Reported differences were significant at P≤.05. All data are reported as mean (±SD) unless otherwise indicated.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

The sample included 982 women aged 35 to 65 years. Of these women, 57.2% (n = 562) were premenopausal, 22.3% (n = 219) were perimenopausal, and 20.5% (n = 201) were postmenopausal.

Demographic characteristics of these 3 groups are given in Table 1. Premenopausal women were younger and more likely to be working than were women in the other 2 groups. Postmenopausal women were more likely to be overweight than were women in the other 2 groups.


View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table 1. Characteristics of the 3 Groups of Women


Menopause had begun at the age of 40 years or younger in 13.6% of women, between 41 and 44 years in 9.3%, at 45 or 46 years in 12.2%, at 47 or 48 years in 16.5%, at 49 or 50 years in 25.5%, at 51 or 52 years in 10%, and at 53 years or older in 11.9%. (Due to rounding percentages may not total 100%.) The mean age at natural menopause was 50.3 (±3.0) years. Hormone therapy was taken by 20.8% of perimenopausal women and 13.2% of postmenopausal women.

PREVALENCE OF HOT FLASHES

A total of 32.8% of the women reported having hot flashes. The prevalence was 12.5% in the group of premenopausal women, rose to 79.0% in the perimenopausal group, and decreased to 39.3% in the postmenopausal group (P<.001). Figure 1 shows this prevalence according to the severity of hot flashes. About half of the women experienced mild hot flashes, nearly one third experienced moderate hot flashes, and 15.5% experienced severe hot flashes. Half (50.9%) of the women experienced night sweats in addition to daytime hot flashes. The median duration of hot flashes was 2 years for premenopausal women, 5 years for perimenopausal women, and 13 years for postmenopausal women.


Figure 600221
View larger version (30K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Prevalence of hot flashes by severity and menopausal status. For a definition of the severity of hot flashes and menopausal status, see the "Definitions" subsection of the "Methods" section.


PREVALENCE OF SYMPTOMS OF CHRONIC INSOMNIA

The presence of chronic insomnia was examined in association with the severity of hot flashes and menopausal status. Chronic insomnia dramatically increased among women with severe hot flashes (Table 2). Of women with severe hot flashes, 81.3% had symptoms of chronic insomnia. Difficulty initiating sleep, NRS, and GSD significantly increased in women with severe hot flashes but were comparable in women with mild hot flashes and those without hot flashes. Chronic DMS increased with the severity of hot flashes.


View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table 2. Insomnia by Severity of Hot Flashes and Menopausal Status


When chronic insomnia was examined in relationship to menopausal status, chronic DIS, NRS, and GSD were more frequent among perimenopausal women. Difficulty maintaining sleep was lower among premenopausal women. One third (31.8%) of perimenopausal and postmenopausal women also reported that, in their opinion, insomnia was related to the development of menopause. Perimenopausal women with hot flashes were more likely to associate insomnia with menopause than were women without hot flashes. This association was not observed, however, in postmenopausal women (Figure 2). When examining the temporal relationship between insomnia and hot flashes, it was found that insomnia predated menopause in 53.1% of perimenopausal women who reported symptoms of insomnia and 21.4% of postmenopausal women (P<.001) (Figure 3).


Figure 600222
View larger version (25K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Association between severity of hot flashes (HF) and insomnia. For a definition of the severity of HF and menopausal status, see the "Definitions" subsection of the "Methods" section.



Figure 600223
View larger version (14K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Temporal relationship between symptoms of insomnia and onset of menopause. Due to rounding percentages do not total 100%.


MULTIVARIATE MODELS

Several factors are likely to affect the bivariate associations observed among insomnia, hot flashes, and menopausal status. Therefore, logistic regression analyses were performed to account for other variables that may have independent effects on chronic insomnia (Table 3).


View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table 3. Adjusted Odds Ratios Among Hot Flashes, Menopausal Status, Health, Demographic Variables, and Chronic Insomnia


Chronic insomnia symptoms were entered as dependent variables. More specifically, 5 models were calculated: chronic DIS, chronic DMS, chronic NRS, at least 1 symptom of chronic insomnia, and GSD. The choice of independent variables was made in conjunction with their positive association with insomnia in bivariate analyses. The models included marital status, occupation, race/ethnicity, severity of hot flashes, menopausal status, perceived health quality, body mass index, hypertension, physical disease, chronic pain, major depressive disorder and anxiety disorders, stress, smoking, alcohol and coffee intake, breathing pauses during sleep, restless legs syndrome, and periodic limb movement symptoms. Age was not entered because of its strong correlation with menopausal status.

The likelihood of having chronic DIS, chronic NRS, or at least 1 symptom of chronic insomnia increased with the severity of hot flashes. Menopausal status was significant only for chronic DMS; postmenopausal women were most likely to report chronic DMS. Other variables significantly associated with insomnia were perception of health as poor, breathing pauses during sleep, and chronic pain. Major depressive disorder was significant only in the model in which at least 1 symptom of chronic insomnia was the dependent variable (Table 3). Similarly, white race was significant only for DMS (OR, 1.5; 95% confidence interval [CI],1.0-2.1; P = .05).

The fifth model, GSD, yielded similar results for the severity of hot flashes, perception of health as poor, chronic pain, and breathing pauses during sleep. Premenopausal and perimenopausal women were more likely to report GSD. In addition, a high level of stress (OR, 1.7; 95% CI, 1.1-2.9; P<.01), drinking at least 3 cups of coffee per day (OR, 1.6; 95% CI, 1.0-2.6; P = .05), and restless legs syndrome (OR, 1.8; 95% CI, 1.1-3.2; P<.05) were associated with GSD.

A sixth model with a diagnosis of insomnia as the dependent variable revealed that perception of health as poor (OR, 3.0; 95% CI, 1.5-5.8; P = .001); mild (OR, 2.2; 95% CI,1.1-4.3; P = .02), moderate (OR, 3.5; 95% CI, 1.8-7.1; P<.001), or severe (OR, 2.5; 95% CI, 1.0-5.9; P = .05) hot flashes; chronic pain (OR, 2.3; 95% CI, 1.4-3.8; P = .002); and white race (OR, 2.0; 95% CI, 1.1-3.6; P = .02) were associated with a diagnosis of insomnia.

Because many women had insomnia predating menopause, women who had chronic insomnia around or after menopause were compared with women with insomnia predating menopause and with women without insomnia, using logistic regression analyses. Only age significantly differentiated women who reported insomnia around or after menopause from those with chronic insomnia predating menopause; perimenopausal and postmenopausal women were older. Chronic pain (OR, 2.2; 95% CI, 1.2-3.9; P = .01) and moderate (OR, 2.8; 95% CI, 1.3-6.4; P = .01) or severe (OR, 3.2; 95% CI, 1.6-6.4; P = .001) hot flashes were associated with chronic insomnia occurring around or after menopause.


COMMENT
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

This study provides evidence that severe hot flashes are associated with chronic insomnia in women aged 35 to 65 years. In general, severe hot flashes increased the likelihood of reporting GSD, chronic DIS, and chronic NRS.

Menopausal status was associated with insomnia only for chronic DMS and GSD. The multiplicity of factors associated with insomnia illustrates the multifactorial aspects of chronic insomnia in women.

Compared with previous epidemiologic studies conducted in women in midlife, this study is unique in several aspects. First, the severity of hot flashes was studied. The dramatic increase in insomnia in women with severe hot flashes indicates that severity of hot flashes should be routinely assessed in all studies of menopause. Second, symptoms of insomnia were defined in terms of frequency and chronicity. This strict definition permitted limitation of the evaluation to the most enduring symptoms of insomnia and not transitory phenomena. Third, the variables assessed covered a broadrange of potential factors associated with insomnia. Most epidemiologic studies had used a limited set of confounding variables to evaluate the association between hot flashes or menopausal status and insomnia.

The prevalence of hot flashes observed in menopausal women in our present study is comparable to that reported in other epidemiologic studies performed in the United States.2-5 Similar prevalence of hot flashes was also reported in Europe,6 Australia,7 and Asia.8-9 In this sample, the age at natural menopause was comparable to that reported in other US studies.32-34

It was found that 56.6% of perimenopausal women and 50.7% of postmenopausal women had at least 1 symptom of chronic insomnia. This is higher than the rate reported in studies that evaluated difficulty sleeping with a single yes-no question. For example, Kravitz et al13 found that 39.6% to 45.4% of perimenopausal and postmenopausal women in the United States reported difficulty sleeping during the 2 weeks before the interview. Another US study reported a rate of about 40% in perimenopausal and postmenopausal women.2 An Australian study found rates between 44% and 52% in perimenopausal and postmenopausal women,7 and a study from China found a rate of about 21% of trouble sleeping in premenopausal, perimenopausal, and postmenopausal women.14

Results showed that chronic insomnia considerably increased in perimenopausal and postmenopausal women compared with premenopausal women; more than half of the women reported DIS, DMS, or NRS. Several studies have attributed the increase in sleep disturbances to hot flashes during perimenopause.10, 35 However, this may be too simplistic, because many other factors, such as chronic pain and poor health, also increased with age. Both of these factors are closely related to insomnia. Their importance is illustrated in the multivariate models; the association between chronic insomnia and menopausal status considerably diminished and even disappeared for DIS and NRS, whereas chronic pain and poor health remained significant. Postmenopausal women still had a higher probability of reporting DMS. A possible explanation is that, because postmenopausal women are older than the other 2 groups of women, this association is mainly due to aging rather than menopausal status. Other sleep disorders, such as periodic limb movements, restless legs syndrome, and obstructive sleep apnea, are known to increase with age and to be associated with insomnia. Periodic limb movements and restless legs syndrome did not reach significant levels in the multivariate models; however, their inclusion decreased the odds between hot flashes and insomnia. When the temporal sequence between menopause and insomnia was examined, it was observed that insomnia predated menopause in about 50% of perimenopausal women and about 20% of postmenopausal women. Moderate and severe hot flashes remained strongly associated with chronic insomnia occurring around or after menopause.

Objective polysomnographic measures of sleep disturbances in menopausal women have yielded conflicting results. Some studies have demonstrated a significant correlation between the occurrence of hot flashes and waking during sleep,36-38 while others found no evidence that hot flashes disturb sleep in healthy women.39-41 Several factors for the lack of association may have influenced the results. Most of these polysomnographic studies are based on samples of fewer than 20 women, with 2 exceptions.39, 41 Therefore, it was difficult to examine the data using different factors such as the severity of hot flashes or the report of frequent nocturnal awakenings. As the results illustrated, about 55% of women with hot flashes had DMS and the number of women with insomnia increased with severe hot flashes. Furthermore, the complaint may not be DMS but other insomnia symptoms such as NRS. It is likely that hot flashes occurring during the night have different levels of severity and cause more or less discomfort, leading to different complaints or no complaint.

This was a cross-sectional study and, therefore, provides a picture of the population at a given point in time. For example, it was possible to identify the association between the severity of hot flashes and chronic insomnia, but the ability to determine whether causality existed was limited. Another limitation is that data are based on self-reports. Measurement of hot flashes relied on individual perceptions and experiences. However, studies that compared subjective and objective measurements of hot flashes found that women reliably described their hot flashes.42-43


CONCLUSIONS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

The results of this study indicate that insomnia in premenopausal, perimenopausal, and postmenopausal women is influenced by several factors, such as chronic pain, poor health, and sleep apnea, which are not related specifically to menopausal status but to aging. On the other hand, hot flashes remain an important factor in insomnia in women in midlife, independent of their menopausal status. Treating hot flashes could improve sleep quality and minimize the deleterious consequences of chronic insomnia.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

Correspondence: Maurice M. Ohayon, MD, DSc, PhD, Stanford Sleep Epidemiology Research Center, Stanford University School of Medicine, 3430 W Bayshore Rd, Palo Alto, CA 94303 (mohayon{at}stanford.edu).

Accepted for Publication: August 17, 2005.

Financial Disclosure: None.

Funding/Support: This research was supported by the Arrillaga Foundation and by an unrestricted grant from NV Organon.

Author Affiliation: Stanford Sleep Epidemiology Research Center, Stanford University School of Medicine, Palo Alto, Calif.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97-111. FULL TEXT | WEB OF SCIENCE | PUBMED
2. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463-473. FREE FULL TEXT
3. McKinlay SM, Jefferts M. The menopausal syndrome. Br J Prev Soc Med. 1974;28:108-115. WEB OF SCIENCE | PUBMED
4. Whiteman MK, Staropoli CA, Langenberg PW, McCarter RJ, Kjerulff KH, Flaws JA. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol. 2003;101:264-272. FULL TEXT | WEB OF SCIENCE | PUBMED
5. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Womens Health. 1998;7:1149-1155. WEB OF SCIENCE | PUBMED
6. Li C, Wilawan K, Samsioe G, Lidfeldt J, Agardh CD, Nerbrand C. Health profile of middle-aged women: the Women's Health in the Lund Area (WHILA) study. Hum Reprod. 2002;17:1379-1385. FREE FULL TEXT
7. Brown WJ, Mishra GD, Dobson A. Changes in physical symptoms during the menopause transition. Int J Behav Med. 2002;9:53-67. PUBMED
8. Sukwatana P, Meekhangvan J, Tamrongterakul T, Tanapat Y, Asavarait S, Boonjitrpimon P. Menopausal symptoms among Thai women in Bangkok. Maturitas. 1991;13:217-228. FULL TEXT | WEB OF SCIENCE | PUBMED
9. Chim H, Tan BH, Ang CC, Chew EM, Chong YS, Saw SM. The prevalence of menopausal symptoms in a community in Singapore. Maturitas. 2002;41:275-282. FULL TEXT | WEB OF SCIENCE | PUBMED
10. Kuh DL, Wadsworth M, Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol. 1997;104:923-933. WEB OF SCIENCE | PUBMED
11. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351-358. FULL TEXT | WEB OF SCIENCE | PUBMED
12. Anderson E, Hamburger S, Liu JH, Rebar RW. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol. 1987;156:428-433. WEB OF SCIENCE | PUBMED
13. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10:19-28. FULL TEXT | WEB OF SCIENCE | PUBMED
14. Ho SC, Chan SG, Yip YB, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas. 1999;33:219-227. FULL TEXT | WEB OF SCIENCE | PUBMED
15. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105. FREE FULL TEXT
16. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60:39-47. FREE FULL TEXT
17. Carter RM, Wittchen HU, Pfister H, Kessler RC. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety. 2001;13:78-88. FULL TEXT | WEB OF SCIENCE | PUBMED
18. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235. FREE FULL TEXT
19. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53:547-554. FULL TEXT | WEB OF SCIENCE | PUBMED
20. Kish L. Survey Sampling. New York, NY: John Wiley & Sons Inc; 1965.
21. Ohayon M. Knowledge Based System Sleep-EVAL: Decisional Trees and Questionnaires. Ottawa, Ontario: National Library of Canada; 1995.
22. Ohayon MM. Improving decision-making processes with the fuzzy logic approach in the epidemiology of sleep disorders. J Psychosom Res. 1999;47:297-311. FULL TEXT | WEB OF SCIENCE | PUBMED
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
24. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Chicago, Ill: American Academy of Sleep Medicine; 1997.
25. Ohayon MM. Validation of expert systems: examples and considerations. Medinfo. 1995;8(pt2):1071-1075. FULL TEXT | PUBMED
26. St-Onge B, Ohayon M. L'utilisation du système Expertal dans un milieu de psychiatrie légale [in French]. Abrégés Congrès Psychiatr Neurol Langue Française. 1994:112.
27. Ohayon MM, Guilleminault C, Zulley J, Palombini L, Raab H. Validation of the Sleep-EVAL system against clinical assessments of sleep disorders and polysomnographic data. Sleep. 1999;22:925-930. WEB OF SCIENCE | PUBMED
28. Hosn R, Shapiro CM, Ohayon MM. Diagnostic concordance between sleep specialists and the Sleep-EVAL system in routine clinical evaluations [abstract]. J Sleep Res. 2000;9:86.
29. World Health Organization. Report of a WHO Scientific Group: Research on the Menopause. Geneva, Switzerland: World Health Organization; 1981. WHO Technical Report Series 670.
30. Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction Br J Psychiatry. 1997;171:382-388. FREE FULL TEXT
31. National Heart, Lung, and Blood Institute. Clinical Guidelines for the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, Md: National Heart, Lung and Blood Institute; 1998.
32. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153:865-874. FREE FULL TEXT
33. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145:124-133. FREE FULL TEXT
34. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;14:103-115. FULL TEXT | WEB OF SCIENCE | PUBMED
35. Owens JF, Matthews KA. Sleep disturbance in healthy middle-aged women. Maturitas. 1998;30:41-50. FULL TEXT | WEB OF SCIENCE | PUBMED
36. Woodward S, Freedman RR. The thermoregulatory effects of menopausal hot flashes on sleep. Sleep. 1994;17:497-501. PUBMED
37. Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL. Association of waking episodes with menopausal hot flushes. JAMA. 1981;245:1741-1744. FREE FULL TEXT
38. Shaver J, Giblin E, Lentz M, Lee K. Sleep patterns and stability in perimenopausal women. Sleep. 1988;11:556-561. WEB OF SCIENCE | PUBMED
39. Polo-Kantola P, Erkkola R, Irjala K, Pullinen S, Virtanen I, Polo O. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril. 1999;71:873-880. FULL TEXT | WEB OF SCIENCE | PUBMED
40. Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril. 2004;82:138-144. FULL TEXT | WEB OF SCIENCE | PUBMED
41. Young T, Rabago D, Zgierska A, Austin D, Laurel F. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep. 2003;26:667-672. WEB OF SCIENCE | PUBMED
42. Finck G, Barton DL, Loprinzi CL, Quella SK, Sloan JA. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage. 1998;16:327-333. FULL TEXT | PUBMED
43. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19:4280-4290. FREE FULL TEXT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sleep-Related Problems in Common Medical Conditions
Parish
Chest 2009;135:563-572.
ABSTRACT | FULL TEXT  

Approach to the Patient with Menopausal Symptoms
Martin and Manson
J. Clin. Endocrinol. Metab. 2008;93:4567-4575.
ABSTRACT | FULL TEXT  

Participant Perspectives on a Yoga Intervention for Menopausal Symptoms
Taylor et al.
Complementary Health Practice Review 2008;13:171-181.
ABSTRACT  

Is It Hot in Here, or Is This Insomnia?
JWatch Women's Health 2006;2006:1-1.
FULL TEXT  

Endocrinology & Metabolism News, August 2006
J. Clin. Endocrinol. Metab. 2006;91:17a-17a.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.